MedPath
TGA Approval

Hospira Desferrioxamine Mesilate 500 mg Powder for Injection vial (137516)

137516

Hospira Desferrioxamine Mesilate 500 mg Powder for Injection vial

Hospira Australia Pty Ltd

April 16, 2007

Medicine

Medicine

Active

Listed - Exempt

Active Ingredients

desferrioxamine mesilate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.